finance.yahoo.com ·
milestone scientific inc q1 2026 212149844
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedMilestone Scientific (medical device company) reported Q1 2026 results: operating expenses down 30% YoY, but revenue flat due to $200k unshipped orders from Strait of Hormuz conflict. Medical revenue doubled on CompuFlo adoption; dental business supported by ambassador program. Company reaffirms 2026 guidance and plans international expansion. The Strait of Hormuz disruption caused a minor logistics delay, not a major supply chain crisis. Impact is company-specific, not sector-wide. Weak commercial mechanism overall.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Milestone Scientific reported 30% YoY reduction in operating expenses for Q1 2026.
- Revenue flat due to $200,000 unshipped orders linked to Strait of Hormuz conflict.
- Medical revenue more than doubled driven by CompuFlo system adoption.
- Reaffirmed 2026 revenue guidance of $9.8M-$10.2M; aims for cash flow breakeven in early 2027.
- Completed $2.15M financing in April 2026; plans product registrations in India, Mexico, Japan by late 2026.
